New data from the VOLITION study reveal that 89% of treatment-naïve individuals with HIV chose to switch to long-acting cabotegravir and rilpivirine after achieving viral suppression with oral DTG/3TC ...

European and Asian stocks markets closed out the week broadly higher Friday following Wall Street's latest record highs ...